MPathy Medical Home
For surgeons

Minitape Minitape O
 
Minitape® is a stabilized, adjustable mesh sling designed by a surgeon specifically for treating female urinary stress incontinence. Minitape® is a minimally invasive solution with three distinct features to increase efficacy: internal fixation anchors, external stabilization, and post-operative adjustment. Minitape® allows for precise intra-operative placement and post-operative adjustment within 72 hours offering you unprecedented cure rates for high risk patients.

Unstabilized minislings are not as effective as full length slings (50-69%). Minitape® delivers a unique patented method which ensures stabilization for the key 72 post-operative hours. This allows for functionality and effectiveness similar to a full length sling. In the long term, the short Minitape® implant ensures a low risk of foreign body complications.

Minitape® also offers the ability to refine or “fine-tune” the sling tension up to 72 hours following the surgery for maximum repairs right in the office. It is estimated that approximately 40% of a primary USI group may need fine-tuning in the office to loosen or tighten the Minitape®.

Mpathy Medical has compiled two years of published data on Minitape® outcomes. Minitape® has a good safety profile and surgeons can place the product under local anesthesia in the office if desired. Patients can return to normal activity and work fairly rapidly.

Minitape® utilizes the patented Smartmesh™ Technology that was designed specifically and exclusively for a women’s anatomy by a surgeon.

Minitape® has a unique closed knit technology which makes it very soft and flexible to the touch. There are finished edges along the sling portion that lays under the urethra verses those that have rough “burred” edges that cause discomfort or create complications in the urethral area. Further because the material does not fold upon itself, twist or deform during implantation, Minitape® maintains broad support of the urethra.

Benefits

  • Two year data on Minitape: safety profile¹:
    • Low incidence of bladder perforations, erosions, and complications
  • Superior outcomes for high risk patients
    • 97% cure rate found in series of 76 patients of whom 22 had instrinsic sphincter deficiency (ISD)²
  • Temporary absorbable sutures allow stabilization during the criticalpost-operative period yielding higher cure rates
  • Intra-operative adjustability to loosen and tighten allows for precise placement
  • Post-operative adjustability for up to 72 hours allows for high cure rates and second reimbursement opportunity when deemed clinically necessary³
  • Utilizes the physiologically compatible, ultra lightweight Smartmesh™ Technology for optimal tissue integration, collagen growth, and near-zero erosion rates
  • Minimal tissue trauma, local anesthesia, less mesh mass
  • Available in two sizes for varying surgical methods - retropubic (12cm) or subfascial (8cm)
Surgical Procedure
 
The Minitape® is stabilized by absorbable sutures which are passed in a retropubic or subfascial course using narrow needles. Within 72 hours, “fine-tuning” adjustments are possible by either loosening or tightening the sutures if needed.
 
Indications for Use
  • All USI patients with particular advantages for:
    • High risk patients with ISD, repeat surgery, obesity, mixed incontinence, voiding disorder,
      or concomitant prolapse repair
Mpathy Medical offers a choice of four ergonomic needles:
  • Intro80: Mini-retropubic
  • Intro60: Mini-retropubic
  • IntroSF: Subfascial
  • IntroHook: Subfascial
Minitape® offers surgeons the ideal procedure by delivering at the highest level of benchmark effectiveness, with minimal incisions and a high safety profile. Additionally, the ability to fine tune may add to that effectiveness.
 
Clinical Data
Smartmesh™ Technology
Restorelle™
Omnisure™
Minitape®

 
Available Needles
Ordering Information

Minitape Ordering Information

1Data on file. ²Alinsod, R. (2009). Recent advances in tape slings for female urinary stress incontinence. Reviews in Obstetrics & Gynecology, 2(1), 46-50. ³Adjustment eligibility is based on the provider's discretion.